{"id":"https://genegraph.clinicalgenome.org/r/d4c6cfe3-fa33-4c52-88e3-8ffeb405fe9cv1.0","type":"EvidenceStrengthAssertion","dc:description":"*SLC26A2* was first associated with autosomal recessive *SLC26A2*-related skeletal dysplasia as early as 1996 (Superti-Furga et al., PMID: 8528239; Hästbacka et al., PMID: 8571951). *SLC26A2* is associated with achondrogenesis type 1B (a fetal/perinatal lethal condition), atelosteogenesis type II, multiple epiphyseal dysplasia (a non-lethal condition), and diastrophic dysplasia depending on level of residual sulfate transport. There is an overlapping phenotypic spectrum with histological and radiographic similarities between clinical presentations. Per criteria outlined by the ClinGen Lumping and Splitting guidelines, the disease entities achondrogenesis type 1B, atelosteogenesis type 2, diastrophic dysplasia, and multiple epiphyseal dysplasia were lumped as a single gene-disease relationship, autosomal recessive *SLC26A2*-related skeletal dysplasia based on similarities in inheritance pattern and phenotype. Evidence supporting this gene-disease relationship includes case-level data and experimental data. At least 15 unique variants (including missense, nonsense, frameshift variants as well as in-frame indels) have been reported in 14 individuals from 8 publications (PMID: 8528239, 8571951, 9637425, 8702490, 8931695, 15316973, 29724173, 30423444). More evidence is available in the literature; however, the maximum score for genetic evidence has been reached. This gene-disease relationship is supported by a knock-out mouse model, a knock-in mouse model, biochemical function, expression studies, and in vitro functional assays (PMID: 30685387, 15703192, 25373420, 25373420, 9575183, 26077908, 11457925, 8931695, 8571951, 8702490). In summary, there is definitive evidence supporting the relationship between *SLC26A2* and autosomal recessive *SLC26A2*-related skeletal dysplasia. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Skeletal Disorders GCEP on the meeting date August 3rd, 2020 (SOP Version 7). ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/d4c6cfe3-fa33-4c52-88e3-8ffeb405fe9c","GCISnapshot":"https://genegraph.clinicalgenome.org/r/48af0749-5b01-4feb-b3a0-9d08cb8e7235","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/48af0749-5b01-4feb-b3a0-9d08cb8e7235_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":"2025-06-02T20:21:59.025Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/48af0749-5b01-4feb-b3a0-9d08cb8e7235_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":"2020-08-03T16:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/48af0749-5b01-4feb-b3a0-9d08cb8e7235_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/48af0749-5b01-4feb-b3a0-9d08cb8e7235_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5c0bfcfb-db6c-489c-8d99-00b21b0c553b","type":"EvidenceLine","dc:description":"The EP decided to downgrade this model to 1 point because while it was a complete knockout, it did not completely recapitulate the human phenotype (for example, accelerated ossification of vertebral bodies was inconsistent with ACG1B).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/418f55dd-1542-424f-9856-8053532e0006","type":"Finding","dc:description":"Features such as short and thick neck, small chest, short limbs, protuberant abdomen, hypoplasia of the long bones, and short ribs are consistent with the presentation of ACG1B in humans.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30685387","rdfs:label":"Zheng Knockout mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/c95d9b9f-6e62-4959-83c9-d4b986ed4c29","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a03b7bec-83c6-479d-a7f8-65bac16b6841","type":"Finding","dc:description":"Thoracic kyphosis, hip dysplasia, and craniofacial malformations are consistent with the diastrophic dysplasia phenotype in humans. In addition, mice also showed reduced growth (60% at postnatal day 60) and decreased motor activity suggestive of joint pain. Histology showed reduced chondrocyte proliferation and biochemical studies showed undersulfated proteoglycans from the femoral diaphysis.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15703192","rdfs:label":"Homozygous A386V knock-in mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/48af0749-5b01-4feb-b3a0-9d08cb8e7235_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d7ba453e-6400-41cc-b34a-f37111f1796a","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3a6c9c01-fed2-4228-a77d-74c874b0a8cf","type":"FunctionalAlteration","dc:description":"Sulfate uptake assays in skin fibroblasts from 3 patients with atelosteogenesis type II showed a defect in uptake of inorganic sulfate. Compared to controls and DTD patients, cells from AO2 patients showed decreased sulfate incorporation during proteoglycan synthesis (as measured by the ratio of 35S to 3H).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8571951","rdfs:label":"Sulfate uptake assay"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/40332874-e45d-485e-94d0-92337fabb8c6","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/65b42c1d-36ce-4569-9539-272e2167a4c3","type":"FunctionalAlteration","dc:description":"In chondrocytes from an achondrogenesis type IB patient (homozygous for p.L483P), both large and small proteoglycans were undersulfated compared to controls.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8702490","rdfs:label":"Proteoglycan sulfation in patient cells"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d972d578-4ee7-485d-b500-3709653cd5e4","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8a41bd3b-564e-4607-bbe3-9105745cc517","type":"FunctionalAlteration","dc:description":"Fibroblasts from all 3 patients had reduced incorporation of sulfate into macromolecules.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8931695","rdfs:label":"Sulfate incorporation assay"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/302b3887-a319-4d5c-a13c-cb8ad5b28ac8","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/690d2529-3879-490d-a954-e5599a3ec57b","type":"FunctionalAlteration","dc:description":"shRNA knockdown of Slc26a2 caused decreased proliferation of chondrocytes (differentiated from mouse progenitor mesenchymal cells) and reduced basal proteoglycan synthesis, possibly by inhibiting the effect of IGF-1 on synthesis.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25373420","rdfs:label":"shRNA knockdown"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/48af0749-5b01-4feb-b3a0-9d08cb8e7235_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/39f1cd47-2e48-4138-a6e9-eba84a8b31ee","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/072366b9-d46e-4926-ac4e-9a8294354c0a","type":"Finding","dc:description":"Decreased sulfate transport has been demonstrated to be a mechanism for variants associated with rMED (and other disorders of the SLC26A2 spectrum) (PMID: 15294877).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9575183","rdfs:label":"Sulfate uptake","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/833870da-c9d4-4c07-bca0-e63a95c97bfd","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/82beecfa-2967-4bca-b9e4-a6f8b38cb093","type":"Finding","dc:description":"In situ hybridization and immunostaining detected SLC26A2 mRNA in developing fetal hyaline cartilage and adult bronchial cartilage.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11457925","rdfs:label":"Expression in human cartilage","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b921d56b-0ce4-4dda-8163-95469ef9b980","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/12672260-9a1a-4b04-ab4b-e67d1281c71d","type":"Finding","dc:description":"In situ hybridization showed that Slc26a2 was expressed in the limbs, craniofacial regions, and lumbosacral spine of mouse embryos at day 14.5.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26077908","rdfs:label":"Expression in mouse embryos","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/474bf7a3-20d5-4c69-a9fe-37cf2207795a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1a2fcb4e-8bb5-4a30-a32a-65fb943e202a","type":"Finding","dc:description":"Immunohistochemistry showed that Slc26a2 was expressed in the chondrocytes of freshly isolated mouse articular cartilage explants.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25373420","rdfs:label":"Expression in mouse articular cartilage","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/48af0749-5b01-4feb-b3a0-9d08cb8e7235_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/57412668-62bf-4e89-856a-083bafc66543_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ebbca8a6-25f1-48db-9873-802018d479c8","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ebbca8a6-25f1-48db-9873-802018d479c8_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional evidence supporting the pathogenicity of the p.Val341del variant (Karniski et al. 2004, PMID: 15294877).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ebbca8a6-25f1-48db-9873-802018d479c8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","allele":{"id":"https://genegraph.clinicalgenome.org/r/27bf6fb9-e4cb-46f3-88fc-a2581286ac2d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.4(SLC26A2):c.1020_1022del (p.Val341del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA259846"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/57412668-62bf-4e89-856a-083bafc66543","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","rdfs:label":"Patient 2","ageType":"AgeAtReport","ageUnit":"Weeks","ageValue":37,"allele":{"id":"https://genegraph.clinicalgenome.org/r/27bf6fb9-e4cb-46f3-88fc-a2581286ac2d"},"ethnicity":{"id":"cg:HispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"achondrogenesis type IB ","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ebbca8a6-25f1-48db-9873-802018d479c8_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/14286e17-6a99-49cd-821d-629559dcac99_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5337be64-66bd-4199-bd60-ae387ec44053","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5337be64-66bd-4199-bd60-ae387ec44053_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","allele":{"id":"https://genegraph.clinicalgenome.org/r/418b4dba-9580-44ca-95f3-7f53732c0ffe","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.4(SLC26A2):c.1724del (p.Lys575SerfsTer10)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252988"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/32a2d16b-c05b-4b0b-a1d7-4391629d13fa","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/32a2d16b-c05b-4b0b-a1d7-4391629d13fa_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional evidence (Karniski et al. 2001, PMID: 11448940)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/32a2d16b-c05b-4b0b-a1d7-4391629d13fa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","allele":{"id":"https://genegraph.clinicalgenome.org/r/04feeafa-ce43-4ccb-aeec-4fd02f8d35e7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.4(SLC26A2):c.1273A>G (p.Asn425Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA259842"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/14286e17-6a99-49cd-821d-629559dcac99","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","rdfs:label":"Patient 6 ","ageType":"AgeAtReport","ageUnit":"Weeks","ageValue":31,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/418b4dba-9580-44ca-95f3-7f53732c0ffe"},{"id":"https://genegraph.clinicalgenome.org/r/04feeafa-ce43-4ccb-aeec-4fd02f8d35e7"}],"firstTestingMethod":"PCR","phenotypeFreeText":"achondrogenesis type IB","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/5337be64-66bd-4199-bd60-ae387ec44053_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/32a2d16b-c05b-4b0b-a1d7-4391629d13fa_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/12b82c84-3fa2-4268-8e14-32eb517251be_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/089f10ae-821d-48f1-a8e4-584a0904ccc5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/089f10ae-821d-48f1-a8e4-584a0904ccc5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Upgraded using experiment from Karniski et al. 2004 (PMID: 15294877) demonstrating that injection of variant cRNA caused minimal sulfate transport function.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/089f10ae-821d-48f1-a8e4-584a0904ccc5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15316973","allele":{"id":"https://genegraph.clinicalgenome.org/r/7d90b82b-8667-4156-a2cb-278cb5f8bc4e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.4(SLC26A2):c.835C>T (p.Arg279Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252990"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e8df80b3-7ed4-4073-84b3-39b17f02a274","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e8df80b3-7ed4-4073-84b3-39b17f02a274_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15316973","allele":{"id":"https://genegraph.clinicalgenome.org/r/a6afec49-27e4-442c-a87c-a41a4717b98d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.4(SLC26A2):c.532C>T (p.Arg178Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA259839"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/12b82c84-3fa2-4268-8e14-32eb517251be","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15316973","rdfs:label":"Macías-Gómez proband","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":9,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/a6afec49-27e4-442c-a87c-a41a4717b98d"},{"id":"https://genegraph.clinicalgenome.org/r/7d90b82b-8667-4156-a2cb-278cb5f8bc4e"}],"detectionMethod":"SLC26A2 only, method not specified.","phenotypeFreeText":"Diagnosed with DTD, but had other features such as wide metaphysis, V-shaped deformity of the distal humerus, thoracic platyspondyly, and horizontal sacrum.","phenotypes":["obo:HP_0003440","obo:HP_0004592","obo:HP_0003063","obo:HP_0000944"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/e8df80b3-7ed4-4073-84b3-39b17f02a274_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/089f10ae-821d-48f1-a8e4-584a0904ccc5_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/5d00d569-4d00-409c-bf6f-2a8e3345cba2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d46119af-8e90-482f-85b8-64cbd74cfe91","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d46119af-8e90-482f-85b8-64cbd74cfe91_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","allele":{"id":"https://genegraph.clinicalgenome.org/r/f83d8d35-6f16-46ee-9a7e-b53cd5c9935c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.4(SLC26A2):c.1194del (p.Ser399HisfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139532190"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/8cfa72f5-4e8e-40f3-a181-4470dbfd3c14","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8cfa72f5-4e8e-40f3-a181-4470dbfd3c14_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","allele":{"id":"https://genegraph.clinicalgenome.org/r/a6afec49-27e4-442c-a87c-a41a4717b98d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/5d00d569-4d00-409c-bf6f-2a8e3345cba2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","rdfs:label":"Patient 5","allele":[{"id":"https://genegraph.clinicalgenome.org/r/a6afec49-27e4-442c-a87c-a41a4717b98d"},{"id":"https://genegraph.clinicalgenome.org/r/f83d8d35-6f16-46ee-9a7e-b53cd5c9935c"}],"firstTestingMethod":"PCR","phenotypeFreeText":"achondrogenesis type IB ","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/8cfa72f5-4e8e-40f3-a181-4470dbfd3c14_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/d46119af-8e90-482f-85b8-64cbd74cfe91_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/1ff52625-b0f3-43a9-99e4-1b75d900f9bc_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/86d86876-1a46-49d0-8949-ecc4b38d8c05","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/86d86876-1a46-49d0-8949-ecc4b38d8c05_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional evidence for the p.Leu483Pro variant (Karniski et al. 2001, PMID: 11448940)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/86d86876-1a46-49d0-8949-ecc4b38d8c05_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8702490","allele":{"id":"https://genegraph.clinicalgenome.org/r/2f7b5656-7d99-4f89-8667-6623c2e79194","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.4(SLC26A2):c.1448T>C (p.Leu483Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA361707892"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/1ff52625-b0f3-43a9-99e4-1b75d900f9bc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8702490","rdfs:label":"Rossi et al. proband","ageType":"AgeAtDeath","ageUnit":"Weeks","ageValue":16,"allele":{"id":"https://genegraph.clinicalgenome.org/r/2f7b5656-7d99-4f89-8667-6623c2e79194"},"phenotypes":["obo:HP_0002866","obo:HP_0000773","obo:HP_0002983","obo:HP_0000256","obo:HP_0003026","obo:HP_0004599"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/86d86876-1a46-49d0-8949-ecc4b38d8c05_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/d31af657-6729-4ed3-b1ec-73b6d79d7e29_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3fa08741-473f-4054-bb4a-69027d82f5bb","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3fa08741-473f-4054-bb4a-69027d82f5bb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional evidence (Karniski et al. 2004, PMID: 15294877)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/3fa08741-473f-4054-bb4a-69027d82f5bb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","allele":{"id":"https://genegraph.clinicalgenome.org/r/6a0982c5-053c-4316-a165-df7d289b31fc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.4(SLC26A2):c.2033G>T (p.Gly678Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA259844"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/44ba0373-8dfa-4729-81d7-9284bd394081","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/44ba0373-8dfa-4729-81d7-9284bd394081_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","allele":{"id":"https://genegraph.clinicalgenome.org/r/a6afec49-27e4-442c-a87c-a41a4717b98d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/d31af657-6729-4ed3-b1ec-73b6d79d7e29","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","rdfs:label":"Patient 4","ageType":"AgeAtReport","ageUnit":"Weeks","ageValue":19,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/6a0982c5-053c-4316-a165-df7d289b31fc"},{"id":"https://genegraph.clinicalgenome.org/r/a6afec49-27e4-442c-a87c-a41a4717b98d"}],"firstTestingMethod":"PCR","phenotypeFreeText":"achondrogenesis type IB","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/3fa08741-473f-4054-bb4a-69027d82f5bb_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/44ba0373-8dfa-4729-81d7-9284bd394081_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/7d35e551-be66-412b-a343-8895a3766008_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b70cd5a3-3a39-4ab6-8ff8-4557a3aec42d","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b70cd5a3-3a39-4ab6-8ff8-4557a3aec42d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional evidence supporting the pathogenicity of the p.Val341del variant (Karniski et al. 2004, PMID: 15294877).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/b70cd5a3-3a39-4ab6-8ff8-4557a3aec42d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","allele":{"id":"https://genegraph.clinicalgenome.org/r/27bf6fb9-e4cb-46f3-88fc-a2581286ac2d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/7d35e551-be66-412b-a343-8895a3766008","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","rdfs:label":"Patient 1","ageType":"AgeAtDeath","ageUnit":"Weeks","ageValue":34,"allele":{"id":"https://genegraph.clinicalgenome.org/r/27bf6fb9-e4cb-46f3-88fc-a2581286ac2d"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0001591","obo:HP_0003811","obo:HP_0012368","obo:HP_0001156","obo:HP_0009826","obo:HP_0008094","obo:HP_0009115"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/b70cd5a3-3a39-4ab6-8ff8-4557a3aec42d_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/1dfd2e44-0d94-40b9-8eac-36622f5e3a5b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d6be274d-25d7-4c0b-b8bf-f9f725e16846","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d6be274d-25d7-4c0b-b8bf-f9f725e16846_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","allele":{"id":"https://genegraph.clinicalgenome.org/r/f6999f97-8c36-4ba4-9e6f-4cc49ce2c06c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.4(SLC26A2):c.451del (p.Tyr151IlefsTer21)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA274352"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/8e69230a-354e-499c-8abb-10b3375a2de6","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e69230a-354e-499c-8abb-10b3375a2de6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","allele":{"id":"https://genegraph.clinicalgenome.org/r/a6afec49-27e4-442c-a87c-a41a4717b98d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/1dfd2e44-0d94-40b9-8eac-36622f5e3a5b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","rdfs:label":"Patient 3","ageType":"AgeAtReport","ageUnit":"Weeks","ageValue":19,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/a6afec49-27e4-442c-a87c-a41a4717b98d"},{"id":"https://genegraph.clinicalgenome.org/r/f6999f97-8c36-4ba4-9e6f-4cc49ce2c06c"}],"ethnicity":{"id":"cg:HispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"achondrogenesis type IB ","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/8e69230a-354e-499c-8abb-10b3375a2de6_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/d6be274d-25d7-4c0b-b8bf-f9f725e16846_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/743a5c1c-b7b4-4569-9257-b81e324a77df_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4ba9973c-99b6-49a8-9e56-a16c4bc62706","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4ba9973c-99b6-49a8-9e56-a16c4bc62706_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional evidence in Karniski 2001 and 2001 (PMID: 11448940, 15294877)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/4ba9973c-99b6-49a8-9e56-a16c4bc62706_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8571951","allele":{"id":"https://genegraph.clinicalgenome.org/r/1bcb8b32-913e-453b-87ef-9e0ce48b26d2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.4(SLC26A2):c.2144C>T (p.Ala715Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252994"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2dbc7e5b-857b-4aab-8175-d4356f89de44","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2dbc7e5b-857b-4aab-8175-d4356f89de44_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional evidence in Karniski 2001 and 2001 (PMID: 11448940, 15294877)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/2dbc7e5b-857b-4aab-8175-d4356f89de44_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8571951","allele":{"id":"https://genegraph.clinicalgenome.org/r/409bc7c7-1b0e-4ea4-b302-e9e2002ac791","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.4(SLC26A2):c.764G>A (p.Gly255Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252992"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/743a5c1c-b7b4-4569-9257-b81e324a77df","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8571951","rdfs:label":"Hastbacka patient 3","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":2,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/409bc7c7-1b0e-4ea4-b302-e9e2002ac791"},{"id":"https://genegraph.clinicalgenome.org/r/1bcb8b32-913e-453b-87ef-9e0ce48b26d2"}],"firstTestingMethod":"PCR","phenotypeFreeText":"This patient was a term baby diagnosed with atelosteogenesis type II. The patient survived for 2 months with intensive care, including ventilation.","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/4ba9973c-99b6-49a8-9e56-a16c4bc62706_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/2dbc7e5b-857b-4aab-8175-d4356f89de44_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/abdf8d19-9c2b-4f90-bfb3-0bf7c3fad539_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/575a1b69-baf7-43af-bcde-73dfba2a0cb8","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/575a1b69-baf7-43af-bcde-73dfba2a0cb8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8931695","allele":{"id":"https://genegraph.clinicalgenome.org/r/1dca2aa0-eaf4-43c2-a758-7f5babb8155d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.4(SLC26A2):c.391del (p.Leu131CysfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252989"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/b2bb73f1-337b-4e14-a510-523f728bf340","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b2bb73f1-337b-4e14-a510-523f728bf340_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional evidence in Karniski 2004 (PMID: 15294877).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/b2bb73f1-337b-4e14-a510-523f728bf340_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8931695","allele":{"id":"https://genegraph.clinicalgenome.org/r/7d90b82b-8667-4156-a2cb-278cb5f8bc4e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/abdf8d19-9c2b-4f90-bfb3-0bf7c3fad539","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8931695","rdfs:label":"Rossi 1996 patient 1","ageType":"AgeAtDeath","ageUnit":"Weeks","ageValue":21,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/7d90b82b-8667-4156-a2cb-278cb5f8bc4e"},{"id":"https://genegraph.clinicalgenome.org/r/1dca2aa0-eaf4-43c2-a758-7f5babb8155d"}],"firstTestingMethod":"SSCP","phenotypeFreeText":"atelosteogenesis type II ","phenotypes":"obo:HP_0009826","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/575a1b69-baf7-43af-bcde-73dfba2a0cb8_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/b2bb73f1-337b-4e14-a510-523f728bf340_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/cf3634b0-2eeb-4173-acc0-5491de1eb00a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/01ec3c93-9d29-4f73-b19b-b1cbf0730f8d","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/01ec3c93-9d29-4f73-b19b-b1cbf0730f8d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29724173","allele":{"id":"https://genegraph.clinicalgenome.org/r/0721285d-8c36-47cd-a03a-47b52e7a3431","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.4(SLC26A2):c.824T>C (p.Leu275Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA361706374"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/18f39900-ca56-44be-9c25-3ee131f9bc5e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/18f39900-ca56-44be-9c25-3ee131f9bc5e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29724173","allele":{"id":"https://genegraph.clinicalgenome.org/r/97e17650-25de-435c-b1cb-a8a294a9ecd4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.4(SLC26A2):c.1198C>T (p.Leu400Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA361707351"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/cf3634b0-2eeb-4173-acc0-5491de1eb00a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29724173","rdfs:label":"Zhou patient 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":12,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/97e17650-25de-435c-b1cb-a8a294a9ecd4"},{"id":"https://genegraph.clinicalgenome.org/r/0721285d-8c36-47cd-a03a-47b52e7a3431"}],"firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Unequal leg lengths were first noticed at 6 yo. Abnormal gait and limping were noted at 9 yo. Had right hip arthroplasty and resection of cartilago acetabularis for limited rotation of the right leg. Chronic synovitis. Lump in the left femoribus internus. Limited flexion-extension of the left leg. Height: 138 cm. Brachydactyly, bilateral skewfoot, lumbosacral scoliosis. Limited movement of both hips.","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/18f39900-ca56-44be-9c25-3ee131f9bc5e_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/01ec3c93-9d29-4f73-b19b-b1cbf0730f8d_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/ba90f7b1-6a40-49d8-9d25-bb956b96d66f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5bc662f0-7290-4712-a6a5-af88c37d47f6","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5bc662f0-7290-4712-a6a5-af88c37d47f6_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional evidence supporting the pathogenicity of the pl.Val341del variant (Karniski et al. 2004, PMID: 15294877).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/5bc662f0-7290-4712-a6a5-af88c37d47f6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9637425","allele":{"id":"https://genegraph.clinicalgenome.org/r/27bf6fb9-e4cb-46f3-88fc-a2581286ac2d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/ba90f7b1-6a40-49d8-9d25-bb956b96d66f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9637425","rdfs:label":"Cai et al. proband","ageType":"AgeAtReport","ageUnit":"Weeks","ageValue":17,"allele":{"id":"https://genegraph.clinicalgenome.org/r/27bf6fb9-e4cb-46f3-88fc-a2581286ac2d"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0003270","obo:HP_0000773","obo:HP_0000883","obo:HP_0008479","obo:HP_0008873","obo:HP_0001789","obo:HP_0006603","obo:HP_0031095","obo:HP_0009815","obo:HP_0009116","obo:HP_0003097","obo:HP_0001552","obo:HP_0000946","obo:HP_0002992","obo:HP_0000887"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/5bc662f0-7290-4712-a6a5-af88c37d47f6_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/75e55080-bda1-47da-bad3-8f5d4a9b4dc1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/766d3119-6463-4f6c-9101-c89eb3520789","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/766d3119-6463-4f6c-9101-c89eb3520789_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional assay in Karniski 2004 (PMID: 15294877)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/766d3119-6463-4f6c-9101-c89eb3520789_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8571951","allele":{"id":"https://genegraph.clinicalgenome.org/r/7d90b82b-8667-4156-a2cb-278cb5f8bc4e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4dd205ca-484a-452a-ae0b-d218ab91549b","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4dd205ca-484a-452a-ae0b-d218ab91549b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8571951","allele":{"id":"https://genegraph.clinicalgenome.org/r/418b4dba-9580-44ca-95f3-7f53732c0ffe"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/75e55080-bda1-47da-bad3-8f5d4a9b4dc1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8571951","rdfs:label":"Hastbacka patient 1","allele":[{"id":"https://genegraph.clinicalgenome.org/r/7d90b82b-8667-4156-a2cb-278cb5f8bc4e"},{"id":"https://genegraph.clinicalgenome.org/r/418b4dba-9580-44ca-95f3-7f53732c0ffe"}],"firstTestingMethod":"PCR","phenotypeFreeText":"Patient 1 was a fetus diagnosed with atelosteogenesis type II. It was the second affected fetus in this family.","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/4dd205ca-484a-452a-ae0b-d218ab91549b_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/766d3119-6463-4f6c-9101-c89eb3520789_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/c4ce73e0-8c74-45c0-93c1-a1e8abfb48a0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/92dbd775-7e9f-46c2-a1ff-76ca16b46c1f","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/92dbd775-7e9f-46c2-a1ff-76ca16b46c1f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30423444","allele":{"id":"https://genegraph.clinicalgenome.org/r/7d90b82b-8667-4156-a2cb-278cb5f8bc4e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/00cf094c-0cdd-4550-a530-54b64d1aec5c","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/00cf094c-0cdd-4550-a530-54b64d1aec5c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30423444","allele":{"id":"https://genegraph.clinicalgenome.org/r/05b50578-afd8-4b15-b4fc-26dc9c4b5640","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.4(SLC26A2):c.1535C>A (p.Thr512Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA116649"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c4ce73e0-8c74-45c0-93c1-a1e8abfb48a0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30423444","rdfs:label":"Kausar patient II","ageType":"AgeAtReport","ageUnit":"Years","ageValue":5,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/7d90b82b-8667-4156-a2cb-278cb5f8bc4e"},{"id":"https://genegraph.clinicalgenome.org/r/05b50578-afd8-4b15-b4fc-26dc9c4b5640"}],"detectionMethod":"Method not specified. SLC26A2 only.","phenotypeFreeText":"At birth, had cleft palate, small jaw, short limbs and length, spontaneous palmar ulnar deviation and underdeveloped thumbs, abnormally shaped femoral heads, and kyphosis with underdeveloped C4. Developed severe progressive scoliosis by 2 yo. At 5 yo, height was 98 cm (-3.0 SD) and weight was 19 kg (0 SD). Stiff ankles but no clubfoot. Valgus deformity at knees, joint stiffness in upper limbs, contractures in third fingers, thick/low-set earlobes. Broad metaphyses, elbow contractures, and bilateral laterally displaced double layer patellae.","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/00cf094c-0cdd-4550-a530-54b64d1aec5c_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/92dbd775-7e9f-46c2-a1ff-76ca16b46c1f_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":10515,"specifiedBy":"GeneValidityCriteria7","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/b0EcUao5K9M","type":"GeneValidityProposition","disease":"obo:MONDO_0100592","gene":"hgnc:10994","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_48af0749-5b01-4feb-b3a0-9d08cb8e7235-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}